Ebola disease
Accidental exposure to Ebola could be managed with antivirals
Source: Lindsey Horton / CDC
Healthcare workers exposed to Ebola virus disease could be managed using a new strategy involving antivirals as post-exposure prophylaxis
For healthcare workers (HCWs) in West Africa, the risk of contracting Ebola virus disease when treating infected patients is not well characterised and there is no consensus on whether to use post-exposure prophylaxis (PEP) after accidental exposure. Now, a UK study published in The Lancet Infectious Diseases[1] has formulated a risk assessment and management strategy.
Eight HCWs who were potentially exposed to the virus were treated according to the strategy. Four HCWs with intermediate or maximum exposure risk received PEP with antiviral agents and follow-up for 42 days. None of the eight HCWs developed Ebola virus disease.
The researchers at the Royal Free London NHS Foundation Trust and Public Health England conclude that new experimental antiviral treatments are a viable option for PEP against Ebola and that standardised risk assessments should be developed to establish their efficacy and safety.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069254
Recommended from Pharmaceutical Press
- Previous
- Next
Minor Illness or Major Disease
This established textbook helps you differentiate between minor illnesses which can be safely managed in the pharmacy, and major diseases.
£43.00Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.